Unlike the B*57 protective effect in HIV-1 infection, in HCV infection there appeared to be no contribution from activating KIR i.e. HLA with similar aKIR binding to B*57 were never significant protective despite sufficient power (model 4). The gene discussed is KIR3DL1; the disease is HIV-1 infection.